Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: exercise

FDA Issues Safety Warning

Michele B. Kaufman, PharmD, BCGP  |  September 25, 2018

The FDA is warning that patients with type 2 diabetes taking SGLT2 inhibitors may be at risk of developing a rare, serious infection, Fournier’s gangrene…

Filed under:Drug Updates Tagged with:Drug SafetyFDAFournier’s gangreneInfectionSGLT2 inhibitorssodium-glucose cotransporter-2 (SGLT2) inhibitorsU.S. Food and Drug Administration (FDA)

Immune Checkpoint Inhibitors & Immune-Related Adverse Events

Priya Chokshi, MD, Roberta Seidman, MD, Noah Levit, PhD, MD, & Steven E. Carsons, MD  |  September 20, 2018

Immune checkpoint inhibitors (ICIs) are at the forefront of advances in cancer therapy and have shown promising results for progression-free survival. Checkpoint signaling pathways, such as cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1), normally regulate the immune response to promote self-tolerance and prevent tissue damage and inflammation. PD-1 is a…

Filed under:ConditionsDrug UpdatesMyositisOther Rheumatic Conditions Tagged with:immune-related adverse eventsirAEsmyositisnivolumab

New Research Shows Knee Osteoarthritis Prevalence Is Rising

Mary Beth Nierengarten  |  September 20, 2018

Studies highlighting the large numbers of people affected by knee osteoarthritis (OA) point to what clinicians who treat knee OA have been seeing for the past few decades: a substantial increase in the prevalence of knee OA in the U.S. and globally. Roughly 250 million people are affected by knee OA worldwide, and about 14…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:body mass index (BMI)knee osteoarthritisphysical activity

For Residents, Mystery Patients Often Require Rheumatologist Advice

Veena S. Katikineni, MD  |  September 20, 2018

As a first-year internal medicine resident, I find myself consulting rheumatologists for just about every mystery patient in our hospital. Like many residents, I was initially intimidated by the complexity of this elusive field. At first glance, diagnosis and management seem completely inaccessible to a first-year resident. But several rheumatology consults later, I can confidently…

Filed under:Education & TrainingProfessional Topics Tagged with:Educationlearning toolsresidentsTraining

Help Your Patients Live Well with Rheumatic Disease

David Daikh, MD, PhD  |  September 20, 2018

As rheumatology professionals, we focus on how to achieve better outcomes for our patients: lower disease activity, remission, milder symptoms and prevention of joint damage or serious complications, such as heart disease. Another outcome is just as important: good quality of life. What can we do to engage our current patients and those at risk…

Filed under:President's Perspective Tagged with:lifestylequality of lifeRheumatic Disease Awareness MonthRheumatic Disease Report Card

The 2018 ACR/ARHP Annual Meeting Program Preview

From the College  |  September 20, 2018

Save the date for the 2018 ACR/ARHP Annual Meeting, Oct. 19–24 in Chicago. Connect with your colleagues for an unmatched educational experience featuring exceptional sessions by leading rheumatology experts. The ACR/ARHP Annual Meeting is your gateway to global rheumatology education. With more than 450 sessions—including The Great Debate—the meeting provides boundless opportunities for professional development,…

Filed under:From the College Tagged with:2018 ACR/ARHP Annual MeetingAssociation of Rheumatology Professionals (ARP)

Coding Corner Question: Coding Scenario for 1997 Musculoskeletal Exam

From the College  |  September 19, 2018

A 55-year-old female patient with pain in multiple joints is referred to the office by her primary care physician. She complains of pain in both knees and both shoulders. She rates the pain at 7 on the pain scale. Her pain is worse at night after she gets off work. Soaking in her hot tub…

Filed under:Billing/CodingFrom the CollegeOsteoarthritis and Bone Disorders Tagged with:Billing & CodingMusculoskeletal

Sessions to Check Out During the 2018 ACR/ARHP Annual Meeting

From the College  |  September 17, 2018

With more than 450 sessions, the 2018 ACR/ARHP Annual Meeting, is your gateway to global rheumatology education. Here is a preview of a few sessions attendees can look forward to…

Filed under:Conditions Tagged with:2018 ACR/ARHP Annual MeetingACR/ARHP Annual Meeting

Promising Avenues in Myositis: Research Targets Disease Specificity

Thomas R. Collins  |  September 10, 2018

AMSTERDAM—Research in myositis treatments is beginning to find its way, with investigators pursuing avenues special to the disease so therapy for patients may no longer involve piggybacking on existing treatments for other illnesses, an expert said at EULAR: the Annual European Congress of Rheumatology. “Finally, in myositis there are targets being investigated that are more…

Filed under:ConditionsEULAR/OtherMeeting ReportsMyositisOther Rheumatic Conditions Tagged with:dermatomyositisEULARExerciseExercise/physical therapymyositisrapamycinTreatment

Dr. Christine Thorburn: From Olympic Cyclist to Rheumatologist

Linda Childers  |  August 17, 2018

Growing up in Iowa, Christine Thorburn, MD, loved to run track and cross-country and dreamed of one day being an Olympic runner. Little did the future rheumatologist know that a knee injury would cause her to change course and become a professional road cyclist who would represent the U.S. in two Olympic Games. Dr. Thorburn…

Filed under:ProfilesRheum After 5 Tagged with:Dr. Christine Thorburn

  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 76
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences